Table 1:
Patient Characteristics
| Variable | 1 Year | 2 Years | |
|---|---|---|---|
| n=265 (%) | n=189(%) | ||
| Age | Under 65 Years | 177 (67) | 134 (71) |
| Over 65 Years | 88 (33) | 55 (29) | |
| BMI | Obese (≥ 30 kg/m2) | 99 (37) | 66 (35) |
| Non-Obese (< 30 kg/m2) | 166 (63) | 123 (65) | |
| Race | White | 251 (95) | 180 (95) |
| Others | 14 (5) | 9 (5) | |
| Diabetes Mellitus | Present | 26 (10) | 16 (9) |
| Absent | 239 (90) | 173 (92) | |
| Nutritional Status | Normal | 187 (71) | 145 (77) |
| Depleted | 69 (26) | 38 (20) | |
| Unknown | 9 (3) | 6 (3) | |
| Disease Stage | Early (Stages I, II) | 78 (29) | 58 (31) |
| Late (Stages III, IV) | 187 (71) | 131 (69) | |
| Cell Histology | Papillary Serous | 187 (71) | 130 (69) |
| Other | 77 (29) | 59 (31) | |
| Unknown | 1 (0) | 0 | |
| Pathology Grade | 1 & 2 | 56 (21) | 42 (22) |
| 3 | 209 (79) | 147 (78) | |
| Cytoreductive Surgery | Optimal | 216 (82) | 156 (87) |
| Suboptimal | 49 (19) | 24 (13) | |
| Closure Technique | Running | 185 (70) | 132 (70) |
| Other | 80 (30) | 57 (30) | |
| Estimated Blood Loss | Less than 800 mL | 189 (71) | 137 (73) |
| More than 800 mL | 76 (29) | 52 (28) | |
| Chemotherapy Mode | Intravenous | 238 (90) | 169 (89) |
| Intraperitoneal | 12 (5) | 10 (5) | |
| None | 15 (6) | 10 (5) | |
| Surgical Site Infection | Present | 32 (12) | 18 (10) |
| Absent | 233 (88) | 171 (91) | |
| Hernia Incidence | Present | 26 (10) | 15 (8) |
| Absent | 239 (90) | 174 (92) | |